• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aptevo Therapeutics Inc (NQ: APVO )

    0.7061 +0.0261 (+3.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 169,967
    Open 0.6875
    Bid (Size) 0.7026 (10)
    Ask (Size) 0.7100 (4)
    Prev. Close 0.6800
    Today's Range 0.6800 - 0.7200
    52wk Range 0.1250 - 10.80
    Shares Outstanding 11,523,716
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
    Via ACCESSWIRE
    Nasdaq Jumps 250 Points; Crude Oil Down 1%
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83.... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities

    Performance

    YTD
    +296.69%
    +296.69%
    1 Month
    -82.39%
    -82.39%
    3 Month
    +355.55%
    +355.55%
    6 Month
    +118.47%
    +118.47%
    1 Year
    -62.84%
    -62.84%

    More News

    Read More
    Why Aptevo Therapeutics Stock Is Cratering
    Via Benzinga
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Aptevo Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Dow Dips 100 Points; CarMax Earnings Miss Views
    Via Benzinga
    Topics Earnings Stocks
    Exposures Financial US Equities
    Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Hub Cyber Security (HUBC) Stock Down 7% Today?
    Via InvestorPlace
    Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
    Via ACCESSWIRE
    Aptevo Therapeutics Provides Pipeline Update
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
    Via Benzinga
    Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
    Via ACCESSWIRE
    APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.